Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.61 |
| ▸ | LPL | P06858 | 9/20 | 0.61 |
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | SNCA | P37840 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | P4HB | P07237 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.30 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.30 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.30 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20109574 | 0.91 | LIPG (0.60) | LIPGLPLCSF1RCYP1A1CYP1B1 | |
| SCHEMBL22697850 | 0.85 | LIPG (0.61) | LIPGLPLCSF1RSNCAP4HB | |
| SCHEMBL22087264 | 0.83 | LIPG (0.50) | LIPGLPLCSF1RCYP1A1CYP1B1 | |
| SCHEMBL24239245 | 0.83 | LPL (0.50) | LIPGLPLCSF1RCYP1A1CYP1B1 | |
| SCHEMBL17807008 | 0.83 | LPL (0.49) | LIPGLPLCSF1RCYP1A1CYP1B1 | |
| SCHEMBL19960893 | 0.82 | LIPG (0.61) | LIPGLPLCSF1RCYP1A1CYP1B1 | |
| SCHEMBL18164752 | 0.82 | LIPG (0.48) | LIPGLPLCSF1RCYP1A1CYP1B1 | |
| SCHEMBL13563025 | 0.81 | PGR (0.43) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| SCHEMBL22161103 | 0.81 | LIPG (0.56) | LIPGLPLCSF1RSNCADGAT1 | |
| SCHEMBL19832039 | 0.81 | LPL (0.48) | LIPGLPLCSF1RCYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180123048-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
| US-20180123048-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180123048-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | LIPG 1295/4885LPL 2598/4885CSF1R 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.